GLP1R and breast carcinoma: Given the above, anti-diabetic and anti-obesity medications such as metformin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have recently emerged as potential therapeutic candidates in the treatment of breast cancer [19].